MedPath

Effect of Shirolepa in Primary Insomnia

Not Applicable
Conditions
Health Condition 1: F510- Insomnia not due to a substance orknown physiological condition
Registration Number
CTRI/2022/09/045226
Lead Sponsor
ochan Acharya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Diagnosed with primary insomnia as per research diagnostic criteria for primary insomnia

2. The insomnia severity index (ISI) score is more than eight points but less than 21 points

Exclusion Criteria

1. Indication of moderate/severe depressive or anxiety symptoms (score > 14 on

the depression scale, score > 10 on the anxiety scale and score > 19 on the

stress scale of DASS-21)

2.Undergoing treatment or had taken any treatment for insomnia in < 3 months

3. Pregnant or lactating women

4.Nocturnal shift-work (i.e., working between 12:00 am and 6:00 am)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insomnia Severity Index (ISI)Timepoint: Baseline (after participant enrollment) <br/ ><br> <br/ ><br>Endpoint (after 7 days of intervention)
Secondary Outcome Measures
NameTimeMethod
Pittsburgh Sleep Quality Index (PSQI), Actigraphy wristwatch sleep parameters, Sleep diary, Epworth Sleepiness Scale (ESS)Timepoint: Baseline (after participant enrollment) <br/ ><br> <br/ ><br>Endpoint (after 7 days of intervention)
© Copyright 2025. All Rights Reserved by MedPath